On July 15, WuXi AppTec (02359.HK) rose 3.23% in regular trading, trading at HK$162.4/share, with turnover of HK$95.15 million.

The rally was driven by multiple international investment banks raising their target prices on the stock, coupled with institutional accumulation. Daiwa significantly raised its target price from HK$138 to HK$190, maintaining a Buy rating, citing Q1 continuing operations revenue growth of 39.4% YoY and adjusted net profit surging 71.7% YoY, both exceeding market expectations. Morgan Stanley raised its H-share target to HK$168, reaffirming the stock as its Top Pick, while Nomura also raised its target price with a Buy rating maintained.

Additionally, JPMorgan Chase acquired approximately 2.37 million and 1.83 million H-shares in early July at prices around HK$155.71 and HK$146.48 respectively, signaling strong institutional conviction. The broader CXO sector has rallied over 21% since early June, supported by accelerating orders and robust innovation drug financing growth expected to sustain sector momentum through the second half.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)